Albert P. Parker - Jan 24, 2023 Form 4 Insider Report for Zynerba Pharmaceuticals, Inc. (ZYNE)

Role
Chief Legal Officer
Signature
/s/ Albert P. Parker
Stock symbol
ZYNE
Transactions as of
Jan 24, 2023
Transactions value $
$0
Form type
4
Date filed
1/25/2023, 04:30 PM
Previous filing
Feb 15, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYNE Common Stock Award $0 +170K +485.71% $0.00 205K Jan 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock award will fully vest in two installments, subject to continued employment with the Company through the applicable vesting date: 1/3 of the restricted stock will vest on February 1, 2024; and 2/3 of the restricted stock will vest on February 1, 2025.